Characteristics | CYC (n = 23) | MMF (n = 34) | P value for significance |
---|---|---|---|
Age, mean ± SD | 46 ± 10.34 | 45.24 ± 13.87 | 0.82 |
Female, n (%) | 18 (78.2) | 31 (91.18) | 0.24 |
Disease duration in years, mean ± SD | 6.04 ± 5.96 | 4.19 ± 2.82 | 0.11 |
Clinical features, n (%) | |||
Breathlessness | 21 (91.3) | 30 (88.2) | 0.53 |
Arthritis | 23 (100) | 28 (82.4) | 0.07 |
Skin changes | 21 (91.3) | 30 (88.2) | 0.53 |
Raynaud’s symptoms | 17 (74) | 18 (52.9) | 0.16 |
Baseline FVC %, mean ± SD | 48.74 ± 15.67 | 53.44 ± 13.69 | 0.23 |
Pulmonary artery hypertension, n (%) | 2 (2.7) | 4 (11.8) | 0.63 |
Anti-scl-70-positive, n (%) | 12 (52.17) | 16 (47.18) | 0.41 |